Putting Medical Under The Microscope

Having spent the majority of his career in academia, it is unsurprising that Juan Ochoa has brought scientific rigour and analysis to his role as Chief Medical Officer at Nestle Health Science. He focuses on commercialising concepts that originate in the laboratory benches by developing value propositions based on clinical and real-world evidence.The former trauma surgeon tells eyeforpharma that the value of a company and the solutions that they bring are ultimately determined by their capacity to solve unmet needs for the end consumer. According to Ochoa, there are several targets in healthcare – the patient, the physician, and the payer. “Wecannot forget that the patient is at the centre, ” he says. “If you are a company that does not generate solutions that are good for the patient, you might get away with this for a little while, but you will not survive long term. It is not only unethical, it also makes you potentially liable and gets you into a lot of trouble. Whatever soluti ons you create have to have a value.”  Value is the word on everyone ’s lips, but Ochoa is dubious when it comes to its penetration into company practices. “I don’t know how the evolution is going – everyone talks about the change from volume to value, but I really don’t know how many talk the talk and walk the walk.”Ochoa has devised a template for an “evidence development process”, which he says ensures a high value product that provides a solution to an unmet need. The...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news